Welcome to our dedicated page for MDA news (Ticker: MDA), a resource for investors and traders seeking the latest updates and insights on MDA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MDA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MDA's position in the market.
MDA Space (TSX: MDA, NYSE: MDA) closed its initial public offering in the United States on March 16, 2026, issuing 9,836,065 common shares at US$30.50 per share for gross proceeds of approximately US$300 million.
Proceeds are intended to fund growth initiatives, customer expansion, potential acquisitions or investments, general corporate purposes, and partial repayment of existing credit facility balances.
New York Stock Exchange published a pre-market update for March 12, 2026 highlighting volatile equities, elevated oil prices, and key market events.
MDA Space (NYSE: MDA) will celebrate its IPO with CEO Mike Greenley ringing the opening bell on March 12, 2026. Other items include Revolut's full UK banking license and market headlines available via the NYSE TV App.